{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiewtryhky3omj3se6rwruky3exvsxch7dzj22kxqzozwn5ti5opuy",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mpovtp6qcog2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreia7iz6aiv5krtoebffcwqx7beuqmtb6yote6dfdvdekcrqnagfo5a"
    },
    "mimeType": "image/jpeg",
    "size": 78541
  },
  "path": "/news/2026-07-prostate-cancer-mutations-reveal-responses.html",
  "publishedAt": "2026-07-02T15:40:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine whether prostate cancers are susceptible to a type of cell death known as ferroptosis. These findings, published in Nature Communications, could help guide treatment strategies for patients whose tumors do not respond to current treatment options.",
  "title": "Two prostate cancer mutations reveal opposite responses to ferroptosis therapy"
}